These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34232295)

  • 1. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
    J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia.
    Lee H; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
    Histopathology; 2021 May; 78(6):814-830. PubMed ID: 33155325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplasia Detected in Patients With Serrated Epithelial Change Is Frequently Associated With an Invisible or Flat Endoscopic Appearance, Nonconventional Dysplastic Features, and Advanced Neoplasia.
    Bahceci D; Alpert L; Storozuk T; Liao X; Yozu M; Westerhoff M; Kővári BP; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Jun; ():. PubMed ID: 38907614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonconventional Dysplasia is Frequently Associated With Goblet Cell Deficient and Serrated Variants of Colonic Adenocarcinoma in Inflammatory Bowel Disease.
    Xiao A; Yozu M; Kővári BP; Yassan L; Liao X; Salomao M; Westerhoff M; Sejben A; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Jun; 48(6):691-698. PubMed ID: 38546105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma: a multicenter clinicopathologic study.
    Choi WT; Yozu M; Miller GC; Shih AR; Kumarasinghe P; Misdraji J; Harpaz N; Lauwers GY
    Mod Pathol; 2020 May; 33(5):933-943. PubMed ID: 31822800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recently described types of dysplasia associated with IBD: tips and clues for the practising pathologist.
    Alipour Z; Stashek K
    J Clin Pathol; 2024 Jan; 77(2):77-81. PubMed ID: 37918911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-conventional dysplasia is frequently associated with low-grade tubuloglandular and mucinous adenocarcinomas in inflammatory bowel disease.
    Akarca FG; Yozu M; Alpert L; Kővári BP; Zhao L; Salomao M; Liao X; Westerhoff M; Lauwers GY; Choi WT
    Histopathology; 2023 Aug; 83(2):276-285. PubMed ID: 37055929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-conventional mucosal lesions (serrated epithelial change, villous hypermucinous change) are frequent in patients with inflammatory bowel disease-results of molecular and immunohistochemical single institutional study.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Virchows Arch; 2020 Feb; 476(2):231-241. PubMed ID: 31375911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients.
    Torres C; Antonioli D; Odze RD
    Am J Surg Pathol; 1998 Mar; 22(3):275-84. PubMed ID: 9500769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease.
    Wen KW; Umetsu SE; Goldblum JR; Gill RM; Kim GE; Joseph NM; Rabinovitch PS; Kakar S; Lauwers GY; Choi WT
    Histopathology; 2019 Oct; 75(4):578-588. PubMed ID: 31111543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypermucinous and goblet cell-deficient, IBD-associated, non-conventional dysplasia besides colorectal adenocarcinoma].
    Almási S; Baráth B; Szaszák P; Kővári B; Sejben A
    Orv Hetil; 2023 Dec; 164(51):2039-2044. PubMed ID: 38142411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia.
    Singhi AD; Waters KM; Makhoul EP; Parian A; Lazarev MG; Proksell SS; Dueker JM; Schwartz MB; Wald AI; Nikiforova MN; Montgomery EA
    Hum Pathol; 2021 Jun; 112():9-19. PubMed ID: 33727167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.
    Krugliak Cleveland N; Huo D; Sadiq F; Sofia MA; Marks J; Cohen RD; Hanauer SB; Turner J; Hart J; Rubin DT
    Gastrointest Endosc; 2018 May; 87(5):1304-1309. PubMed ID: 29307473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased histologic inflammation is an independent risk factor for nonconventional dysplasia in ulcerative colitis.
    Nguyen ED; Wang D; Lauwers GY; Choi WT
    Histopathology; 2022 Nov; 81(5):644-652. PubMed ID: 35942654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conventional and non-conventional dysplasia in patients with inflammatory bowel disease].
    Enea D; Lauwers G; Svrcek M
    Ann Pathol; 2023 Jun; 43(3):180-191. PubMed ID: 36906454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological subtypes of colorectal low-grade intraepithelial neoplasia: diagnostic reproducibility, frequency and clinical impact.
    Lang-Schwarz C; Büttner-Herold M; Burian S; Erber R; Hartmann A; Jesinghaus M; Kamarádová K; Rubio CA; Seitz G; Sterlacci W; Vieth M; Bertz S
    J Clin Pathol; 2023 Nov; ():. PubMed ID: 37985140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia.
    Cremer A; Demetter P; De Vos M; Rahier JF; Baert F; Moreels T; Macken E; Louis E; Ferdinande L; Fervaille C; Dedeurwaerdere F; Bletard N; Driessen A; De Hertogh G; Vermeire S; Franchimont D;
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1528-1536.e5. PubMed ID: 31202983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.